Human Papillomavirus Vaccines: An Updated Review
- PMID: 32708759
- PMCID: PMC7565290
- DOI: 10.3390/vaccines8030391
Human Papillomavirus Vaccines: An Updated Review
Abstract
Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past decade, have shown promising results in decreasing HPV infection and related diseases, such as warts and precancerous lesions. In this review, we present the updated information about current HPV vaccines, focusing on vaccine coverage and efficacy. In addition, pan-gender vaccination and current clinical trials are also discussed. Currently, more efforts should be put into increasing the vaccine's coverage, especially in low- and middle-income countries. Provision of education on HPV and vaccination is one of the most important methods to achieve this. Vaccines that target HPV types not included in current vaccines are the next stage in vaccine development. In the future, all HPV-related cancers, such as head and neck cancer, and anal cancer, should be tracked and evaluated, especially in countries that have introduced pan-gender vaccination programs. Therapeutic vaccines, in combination with other cancer treatments, should continue to be investigated.
Keywords: Cervarix; Gardasil; Gardasil 9; human papillomavirus; vaccine.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Similar articles
-
Human papillomavirus vaccines.Ann Pharmacother. 2006 Jul-Aug;40(7-8):1344-52. doi: 10.1345/aph.1G723. Epub 2006 Jul 18. Ann Pharmacother. 2006. PMID: 16849621 Review.
-
Clinical update of the AS04-adjuvanted human papillomavirus-16/18 cervical cancer vaccine, Cervarix.Adv Ther. 2009 Nov;26(11):983-98. doi: 10.1007/s12325-009-0079-5. Epub 2009 Dec 18. Adv Ther. 2009. PMID: 20024678 Review.
-
Second-generation prophylactic HPV vaccines: current options and future strategies for vaccines development.Minerva Med. 2016 Feb;107(1):26-38. Epub 2015 Oct 16. Minerva Med. 2016. PMID: 26473283 Review.
-
[The importance of HPV vaccination in men].Cas Lek Cesk. 2016;155(4):34-9. Cas Lek Cesk. 2016. PMID: 27481200 Review. Czech.
-
Comparison of the immunogenicity and safety of Cervarix and Gardasil human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years.Hum Vaccin. 2009 Oct;5(10):705-19. doi: 10.4161/hv.5.10.9518. Epub 2009 Oct 14. Hum Vaccin. 2009. PMID: 19684472 Clinical Trial.
Cited by
-
Use of virus-like particles and nanoparticle-based vaccines for combating picornavirus infections.Vet Res. 2024 Sep 30;55(1):128. doi: 10.1186/s13567-024-01383-x. Vet Res. 2024. PMID: 39350170 Free PMC article. Review.
-
Assessing Saudi women's awareness about human papillomavirus (HPV) and their susceptibility to receive the vaccine.Hum Vaccin Immunother. 2024 Dec 31;20(1):2395086. doi: 10.1080/21645515.2024.2395086. Epub 2024 Sep 2. Hum Vaccin Immunother. 2024. PMID: 39219415 Free PMC article.
-
Transoral Robotic Surgery and Human Papillomavirus Infection: Impact on Oropharyngeal Cancer Prognosis.J Clin Med. 2024 Jul 30;13(15):4455. doi: 10.3390/jcm13154455. J Clin Med. 2024. PMID: 39124727 Free PMC article.
-
Surgical treatment of perineal giant condylomata acuminata (Buschke Lowenstein tumor): Case series from a developing country.Int J Surg Case Rep. 2024 Aug;121:109994. doi: 10.1016/j.ijscr.2024.109994. Epub 2024 Jul 5. Int J Surg Case Rep. 2024. PMID: 38981296 Free PMC article.
-
Hybrid-Capture Target Enrichment in Human Pathogens: Identification, Evolution, Biosurveillance, and Genomic Epidemiology.Pathogens. 2024 Mar 23;13(4):275. doi: 10.3390/pathogens13040275. Pathogens. 2024. PMID: 38668230 Free PMC article. Review.
References
-
- Brianti P., De Flammineis E., Mercuri S.R. Review of HPV-related diseases and cancers. New Microbiol. 2017;40:80–85. - PubMed
-
- Pastrana D.V., Peretti A., Welch N.L., Borgogna C., Olivero C., Badolato R., Notarangelo L.D., Gariglio M., FitzGerald P.C., McIntosh C.E., et al. Metagenomic Discovery of 83 New Human Papillomavirus Types in Patients with Immunodeficiency. mSphere. 2018;3:e00645-18. doi: 10.1128/mSphereDirect.00645-18. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous